Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bullock

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|May 11, 2005
Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warningsRoger Bullock
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2010
Defining optimal treatment with cholinesterase inhibitors in Alzheimer's diseaseGary Small, Roger Bullock
International Journal of Geriatric Psychiatry|January 8, 2005
Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literatureRoger Bullock, Luc Truyen
Current Alzheimer Research|July 14, 2007
Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesteraseRoger Bullock, Roger Lane
Alzheimer Disease and Associated Disorders|September 27, 2003
Realistic expectations: the management of severe Alzheimer diseaseRoger Bullock, Gerry Hammond
International Journal of Geriatric Psychiatry|March 29, 2002
Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?Roger Bullock, Claire Connolly
Dementia and Geriatric Cognitive Disorders|October 16, 2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamineRoger Bullock, Timo Erkinjuntti, Sean Lilienfeld, et al.
Age and Ageing|June 15, 2007
Can we afford not to have integrated dementia services?Roger Bullock, Steve Iliffe, Peter Passmore
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Treatment-Refractory Depression in the Elderly: An Audit of Primary Care Referrals to Psychiatric Services in Swindon, U.KPatrick Brooke, Mari Jones-Ritson, Roger Bullock
Current Medical Research and Opinion|August 15, 2009
Cholinesterase inhibition: is there evidence for disease-modifying effects?Michael Shanks, Miia Kivipelto, Roger Bullock, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|May 11, 2005
Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warningsRoger Bullock
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2010
Defining optimal treatment with cholinesterase inhibitors in Alzheimer's diseaseGary Small, Roger Bullock
International Journal of Geriatric Psychiatry|January 8, 2005
Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literatureRoger Bullock, Luc Truyen
Current Alzheimer Research|July 14, 2007
Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesteraseRoger Bullock, Roger Lane
Alzheimer Disease and Associated Disorders|September 27, 2003
Realistic expectations: the management of severe Alzheimer diseaseRoger Bullock, Gerry Hammond
International Journal of Geriatric Psychiatry|March 29, 2002
Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?Roger Bullock, Claire Connolly
Dementia and Geriatric Cognitive Disorders|October 16, 2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamineRoger Bullock, Timo Erkinjuntti, Sean Lilienfeld, et al.
Age and Ageing|June 15, 2007
Can we afford not to have integrated dementia services?Roger Bullock, Steve Iliffe, Peter Passmore
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Treatment-Refractory Depression in the Elderly: An Audit of Primary Care Referrals to Psychiatric Services in Swindon, U.KPatrick Brooke, Mari Jones-Ritson, Roger Bullock
Current Medical Research and Opinion|August 15, 2009
Cholinesterase inhibition: is there evidence for disease-modifying effects?Michael Shanks, Miia Kivipelto, Roger Bullock, et al.
Pageof 7